Economist
0
HTA and cell and gene therapy – Healthcare Economist
0

An article by Drummond et al. (2023) The article examines how health technology assessment bodies are tackling the ...

0
How much do narrow networks impact premiums? – Healthcare Economist
0

Patients hate limited networks. They dislike anything that limits their choice of doctors or hospitals. Americans like ...

0
Impact of Education on Mortality – Healthcare Economist
0

It makes sense that people with higher education levels have lower mortality rates. Better education can improve health literacy. Higher education levels ...

0
How would the inclusion of specialty drugs impact CPI-Rx? – Healthcare Economist
0

The Bureau of Labor Statistics (BLS) Consumer Price Index for Prescription Drugs (CPI-Rx) analyzes price changes for drugs dispensed at retail pharmacies ...

0
340B costs Medicaid $32b per year – Healthcare Economist
0

He 340B Drug Pricing Program is a federal initiative designed to help certain health care providers, known as "covered entities," stretch their resources ...

0
Empirical Estimates of Loss Aversion – Healthcare Economist
0

Kahneman and Tversky's prospect theory They postulate that individuals have loss aversion. What is loss aversion? This means that people experience ...

0
Drug shortages in the US – Healthcare Economist
0

The good news: Drug shortages in 2023 have declined in the United States from their recent peak between 2010 and 2012. ...

0
US Health Insurance Trends: 2024-2034 – Healthcare Economist
0

The Congressional Budget Office (CBO) recently provided projections of U.S. health insurance levels between 2024 and ...

0
Challenges in Conducting Economic Evaluations for Orphan Drugs in Rare Diseases – Healthcare Economist
0

Why is it so difficult to estimate the value of orphan drugs indicated for the treatment of rare diseases? There are a ...

0
Time is money in drug development – Healthcare Economist
0

Delays in drug approval cost pharmaceutical companies money. These costs include both lost sales and the additional cost if clinical trials need to last ...

Tools4BLS
Logo
Register New Account
Compare items
  • Total (0)
Compare
0
Shopping cart